| PubMed | Title | Journal | Year | Linked by |
|---|
| PMID 40148593 | Organoids - the future of pre-clinical development of AAV gene therapy for CNS disorders. | Gene therapy | 2026 | name in abstract: Luxturna |
| PMID 41343897 | Promises past and future - Gene therapy and the actualisation of future expectations. | Social science & medicine (1982) | 2026 | name in abstract: Luxturna |
| PMID 41379738 | Chorioretinal Atrophy after Voretigene Neparvovec Therapy in RPE65 Mutation-Associated Inherited Retinal Disease: Longitudinal Characterization in Multimodal Imaging. | Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde | 2026 | name in title: voretigene neparvovec |
| PMID 41481309 | Vision Outcomes in Children Treated With Voretigene Neparvovec for RPE65-Associated Retinopathy. | JAMA ophthalmology | 2026 | name in title: voretigene neparvovec |
| PMID 41520727 | Biologics-device combinations: Enabling prolonged therapies in the posterior segment ocular disease. | Advanced drug delivery reviews | 2026 | name in abstract: Luxturna |
| PMID 41679721 | Gene therapy outcomes in young patients with RPE65-retinal degeneration. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie | 2026 | name in abstract: voretigene neparvovec |
| PMID 41758347 | Real-world safety of voretigene neparvovec: a disproportionality analysis for signal detection using the FAERS database. | Naunyn-Schmiedeberg's archives of pharmacology | 2026 | name in title: voretigene neparvovec |
| PMID 41853567 | Expert Consensus on Characteristics, Etiology, and Management of Chorioretinal Atrophy in Patients Treated with Voretigene Neparvovec. | Ophthalmology science | 2026 | name in title: voretigene neparvovec |
| PMID 41933930 | Adeno-Associated Virus Gene Delivery to Hard-to-Transduce Tissues: Biological Barriers, Engineering Strategies, and Clinical Challenges. | Human gene therapy | 2026 | name in abstract: Luxturna |
| PMID 41998128 | Structural, functional and patient-reported 24-month outcomes of voretigene neparvovec in Portuguese patients with RPE65-associated disease. | Eye (London, England) | 2026 | name in title: voretigene neparvovec |
| PMID 42074510 | Gene-Agnostic Therapeutic Strategies for Inherited Retinal Diseases: Neuroprotection and Immunomodulation. | Genes | 2026 | name in abstract: voretigene neparvovec |
| PMID 42117798 | Voretigene Neparvovec Gene Therapy in Clinical Practice: A 12-Month, Single-Center, In-Depth Analysis of Beneficial and Adverse Drug Effects. | Translational vision science & technology | 2026 | name in title: voretigene neparvovec |
| PMID 42137601 | Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates. | Molecular therapy. Advances | 2026 | name in abstract: voretigene neparvovec |
| PMID 42299455 | Microperimetry is a valuable tool for assessing changes in visual function following voretigene neparvovec-rzyl gene therapy. | Ophthalmic genetics | 2026 | name in title: voretigene neparvovec |
| PMID 42331100 | Clinical Experience with Gene Therapy for Autosomal Recessive RPE65-Related Retinal Dystrophy in the United Arab Emirates. | Ophthalmology. Retina | 2026 | name in abstract: voretigene neparvovec |
| PMID 42346599 | Genetic Testing in Inherited Retinal Disease: Current Strategies and Future Directions. | Journal of personalized medicine | 2026 | name in abstract: voretigene neparvovec |
| PMID 42346603 | Precision Medicine in Inherited Retinal Disease: Advances, Challenges, and Future Directions. | Journal of personalized medicine | 2026 | name in abstract: Luxturna |
| PMID 42365082 | Clinical and genetic characteristics of RPE65-associated inherited retinal degeneration in Koreans. | Scientific reports | 2026 | name in abstract: voretigene neparvovec |
| PMID 42425207 | Post-approval outcomes of voretigene neparvovec (Luxturna®) retinal gene therapy: A systematic review and meta-analysis. | Survey of ophthalmology | 2026 | name in title: voretigene neparvovec |
| PMID 42449943 | Trends in the Engineering of Adeno-Associated Virus (AAV) for Precision Gene Delivery to the Central Nervous System (CNS). | International journal of molecular sciences | 2026 | name in abstract: Luxturna |
| PMID 42486371 | Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States. | Ophthalmology | 2026 | name in title: voretigene neparvovec |
| PMID 42674265 | Voretigene Neparvovec (Luxturna) for Biallelic RPE65-Associated Retinal Dystrophy: Systematic Review. | American journal of ophthalmology | 2026 | name in title: voretigene neparvovec |
| PMID 42839681 | The Price of a Cure: Luxturna and the Economic Dilemmas of Precision Medicine. | The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics | 2026 | name in title: Luxturna |
| PMID 42848340 | Durable Safety and Efficacy of Voretigene Neparvovec-Rzyl in Postapproval Studies in the USA: CRAning for Perfection. | Ophthalmology | 2026 | name in title: voretigene neparvovec |
| PMID 42901316 | Mastering the eye: Clinical paradigm shifts from optical restoration to genomic correction. | Progress in retinal and eye research | 2026 | name in abstract: voretigene neparvovec |
| PMID 42927978 | Does Route of Administration Affect the Outcome of Retinal Gene Therapy Clinical Trials? | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics | 2026 | name in abstract: voretigene neparvovec |
| PMID 39039945 | Genetic counselors' awareness and attitudes regarding gene therapies. | Journal of genetic counseling | 2025 | name in abstract: voretigene neparvovec |
| PMID 39418576 | THE FIGHT INHERITED RETINAL BLINDNESS! PROJECT: A New Treatment Outcome and Natural History Registry for Inherited Retinal Disease. | Retina (Philadelphia, Pa.) | 2025 | name in abstract: voretigene neparvovec |
| PMID 39578019 | 12-month outcomes after voretigene neparvovec gene therapy in paediatric patients with RPE65-mediated inherited retinal dystrophy. | The British journal of ophthalmology | 2025 | name in title: voretigene neparvovec |
| PMID 39739008 | Canine models of inherited retinal diseases: from neglect to well-recognized translational value. | Mammalian genome : official journal of the International Mammalian Genome Society | 2025 | name in abstract: voretigene neparvovec |
| PMID 39745677 | Deep Learning-Based SD-OCT Layer Segmentation Quantifies Outer Retina Changes in Patients With Biallelic RPE65 Mutations Undergoing Gene Therapy. | Investigative ophthalmology & visual science | 2025 | name in abstract: voretigene neparvovec |
| PMID 39828244 | Insights into the effects of subretinal voretigene neparvovec-rzyl in RPE65-associated Leber congenital amaurosis. | Canadian journal of ophthalmology. Journal canadien d'ophtalmologie | 2025 | name in title: voretigene neparvovec |
| PMID 39900645 | Real-world outcomes of Voretigene Neparvovec: a single-centre consecutive case series. | Eye (London, England) | 2025 | name in title: voretigene neparvovec |
| PMID 39920348 | Foveal detachment in voretigene neparvovec administration: essential step or avoidable risk? | Eye (London, England) | 2025 | name in title: voretigene neparvovec |
| PMID 39941570 | Pre-Clinical and Clinical Advances in Gene Therapy of X-Linked Retinitis Pigmentosa: Hope on the Horizon. | Journal of clinical medicine | 2025 | name in abstract: Luxturna |
| PMID 39943983 | Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in RPE65. | Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V | 2025 | name in abstract: voretigene neparvovec |
| PMID 39956654 | Evaluating ocular health in retinal gene therapies. | Clinical & experimental optometry | 2025 | name in abstract: voretigene neparvovec |
| PMID 39989340 | A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease. | Human gene therapy | 2025 | name in abstract: Luxturna |
| PMID 40027263 | Cell-penetrating peptide-grafted AAV2 capsids for improved retinal delivery via intravitreal injection. | Molecular therapy. Methods & clinical development | 2025 | name in abstract: Luxturna |
| PMID 40087508 | Voretigene neparvovec in RPE65-related inherited retinal dystrophy: the 1-year real-world study LIGHT. | Eye (London, England) | 2025 | name in title: voretigene neparvovec |
| PMID 40104153 | Validation of a quantitative cell-based relative potency assay for LUXTURNA. | Molecular therapy. Methods & clinical development | 2025 | name in title: Luxturna |
| PMID 40204976 | Improvements induced by retinal gene therapy with voretigene neparvovec depend on visual cortical hemispheric dominance mechanisms. | Communications medicine | 2025 | name in title: voretigene neparvovec |
| PMID 40268248 | Retina-directed gene therapy: Achievements and remaining challenges. | Pharmacology & therapeutics | 2025 | name in abstract: voretigene neparvovec |
| PMID 40334704 | Correction: Letter to the editor relating to Stingl K, Priglinger C, Herrmann P. "RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec" Klin Monbl Augenheilkd 2024; 241(03): 259-265. DOI: 10.1055/a-2227-3671. | Klinische Monatsblatter fur Augenheilkunde | 2025 | name in title: voretigene neparvovec |
| PMID 40602323 | Viral and non-viral vectors in gene therapy: current state and clinical perspectives. | EBioMedicine | 2025 | name in abstract: Luxturna |
| PMID 40689376 | Assessment of the official national insurance coverage of regenerative medical products for ophthalmic diseases in Japan following regulatory approval. | Regenerative therapy | 2025 | name in abstract: Luxturna |
| PMID 40701540 | [Inherited retinal disorders: Current therapeutic options and future perspectives]. | Klinische Monatsblatter fur Augenheilkunde | 2025 | name in abstract: Luxturna |
| PMID 40725503 | Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future Directions. | Genes | 2025 | name in abstract: voretigene neparvovec |
| PMID 40731809 | Retinitis Pigmentosa: From Genetic Insights to Innovative Therapeutic Approaches-A Literature Review. | Medicina (Kaunas, Lithuania) | 2025 | name in abstract: voretigene neparvovec |
| PMID 40736857 | A Practical Approach to Retinal Dystrophies. | Advances in experimental medicine and biology | 2025 | name in abstract: voretigene neparvovec |
| PMID 40736861 | "Seeing Stars": The Gene Therapy Revolution. | Advances in experimental medicine and biology | 2025 | name in abstract: voretigene neparvovec |
| PMID 40805927 | Pharmacoeconomic Profiles of Advanced Therapy Medicinal Products in Rare Diseases: A Systematic Review. | Healthcare (Basel, Switzerland) | 2025 | name in abstract: voretigene neparvovec |
| PMID 40840866 | Retinal Viral Gene Therapy: Impact of Route of Administration on Serious Adverse Events-A Systematic Review. | Clinical & experimental ophthalmology | 2025 | name in abstract: Luxturna |
| PMID 40864185 | [Gene therapy methods for rare ophthalmological diseases in the light of distributional justice-An overview]. | Die Ophthalmologie | 2025 | name in abstract: Luxturna |
| PMID 40869487 | Genetic Therapies for Retinitis Pigmentosa: Current Breakthroughs and Future Directions. | Journal of clinical medicine | 2025 | name in abstract: voretigene neparvovec |
| PMID 40910102 | Efficacy and Safety of Voretigene Neparvovec in RPE65-Retinopathy: Results of a Phase III Trial in Japan. | Ophthalmology science | 2025 | name in title: voretigene neparvovec |
| PMID 40911667 | Retinal gene therapy using epiretinal AAV-containing fibrin hydrogel implants. | Science advances | 2025 | name in abstract: voretigene neparvovec |
| PMID 41001995 | SNAC: A Single-Nuclei Atlas of Capsid Distribution in Nonhuman Primate Eye. | Human gene therapy | 2025 | name in abstract: voretigene neparvovec |
| PMID 41054259 | One down but many more to go: the state of gene therapy for inherited retinal disease. | Regenerative medicine | 2025 | name in abstract: voretigene neparvovec |
| PMID 41138048 | Can Gene Therapy Transform the Treatment Landscape of Posterior Segment Eye Diseases? A Comprehensive Review of Recent Advancements. | Drugs | 2025 | name in abstract: voretigene neparvovec |
| PMID 41140124 | Clinical and pharmacovigilance safety evaluation of LUXTURNA® (voretigene neparvovec-rzyl). | Cutaneous and ocular toxicology | 2025 | name in title: voretigene neparvovec |
| PMID 41235102 | Gene Therapy in Rare Genetic Disorders: Current Progress and Future Perspectives. | Current genomics | 2025 | name in abstract: Luxturna |
| PMID 41362291 | Nonclinical toxicity study duration in AAV gene therapy development: Evidence from industry survey supports adequacy of short-term assessments. | Molecular therapy. Methods & clinical development | 2025 | name in abstract: Luxturna |
| PMID 41440982 | Gene Therapy for Inherited Retinal Disease: Current Strategies, Personalized Medicine, and Future Implications-A Comprehensive Review. | Journal of personalized medicine | 2025 | name in abstract: voretigene neparvovec |
| PMID 41463332 | Mechanisms and Functions of Chromophore Regeneration in the Classical Visual Cycle: Implications for Retinal Disease Pathogenesis and Therapy. | Biomolecules | 2025 | name in abstract: voretigene neparvovec |
| PMID 37704110 | Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting. | Ophthalmology | 2024 | name in title: voretigene neparvovec |
| PMID 37715554 | A morphometric analysis of the retinal arterioles with adaptive optics imaging in RPE65-associated retinal dystrophy after treatment with voretigene neparvovec. | Acta ophthalmologica | 2024 | name in title: voretigene neparvovec |
| PMID 37768368 | Multi-luminance mobility testing after gene therapy in the context of retinal functional diagnostics. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2024 | name in abstract: voretigene neparvovec |
| PMID 38044158 | Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases. | Trends in molecular medicine | 2024 | name in abstract: voretigene neparvovec |
| PMID 38218527 | Investing in vision: Innovation in retinal therapeutics and the influence on venture capital investment. | Progress in retinal and eye research | 2024 | name in abstract: Luxturna |
| PMID 38279252 | The Clinical Findings, Pathogenic Variants, and Gene Therapy Qualifications Found in a Leber Congenital Amaurosis Phenotypic Spectrum Patient Cohort. | International journal of molecular sciences | 2024 | name in abstract: Luxturna |
| PMID 38295874 | Objective Outcomes to Evaluate Voretigene Neparvovec Treatment Effects in Clinical Practice. | Ophthalmology. Retina | 2024 | name in title: voretigene neparvovec |
| PMID 38376864 | Chorioretinal Atrophy Growth After Voretigene Neparvovec Retinotopically Is Connected to Retinal Functional Rescue. | Translational vision science & technology | 2024 | name in title: voretigene neparvovec |
| PMID 38384245 | Recent developments in gene therapy research in India. | Journal of biosciences | 2024 | name in abstract: Luxturna |
| PMID 38450707 | Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene Therapy. | Clinical pharmacology and therapeutics | 2024 | name in abstract: voretigene neparvovec |
| PMID 38508214 | RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec. | Klinische Monatsblatter fur Augenheilkunde | 2024 | name in title: voretigene neparvovec |
| PMID 38612516 | Retention Rates of Genetic Therapies Based on AAV Serotypes 2 and 8 Using Different Drug-Delivery Materials. | International journal of molecular sciences | 2024 | name in abstract: voretigene neparvovec |
| PMID 38627549 | Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice. | Eye (London, England) | 2024 | name in title: voretigene neparvovec |
| PMID 39078952 | Gene therapy for retinal diseases: From genetics to treatment. | Indian journal of ophthalmology | 2024 | name in abstract: Luxturna |
| PMID 39141279 | Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl. | Documenta ophthalmologica. Advances in ophthalmology | 2024 | name in title: voretigene neparvovec |
| PMID 39322487 | Adeno-associated virus therapies: Pioneering solutions for human genetic diseases. | Cytokine & growth factor reviews | 2024 | name in abstract: Luxturna |
| PMID 39353611 | Erratum: RPE65-associated retinal dystrophies: phenotypes and treatment effects with voretigene neparvovec. | Klinische Monatsblatter fur Augenheilkunde | 2024 | name in title: voretigene neparvovec |
| PMID 39439625 | Advances and Challenges in Gene Therapy for Inherited Retinal Dystrophies: A Comprehensive Review. | Cureus | 2024 | name in abstract: Luxturna |
| PMID 39489915 | Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: A comprehensive review. | Molecular therapy : the journal of the American Society of Gene Therapy | 2024 | name in abstract: voretigene neparvovec |
| PMID 39598155 | Infantile Nystagmus Syndrome-Associated Inherited Retinal Diseases: Perspectives from Gene Therapy Clinical Trials. | Life (Basel, Switzerland) | 2024 | name in abstract: voretigene neparvovec |
| PMID 39685816 | Novel Therapies for Inherited Retinal Dystrophies. | Journal of clinical medicine | 2024 | name in abstract: voretigene neparvovec |
| PMID 39703610 | Ocular Gene Therapy: An Overview of Viral Vectors, Immune Responses, and Future Directions. | The Yale journal of biology and medicine | 2024 | name in abstract: voretigene neparvovec |
| PMID 39870365 | Correction: RPE65-associated retinal dystrophies: phenotypes and treatment effects with voretigene neparvovec. | Klinische Monatsblatter fur Augenheilkunde | 2024 | name in title: voretigene neparvovec |
| PMID 33394965 | Surgical Observations From the First 120 Cases of Subretinal Gene Therapy for Inherited Retinal Diseases. | Retina (Philadelphia, Pa.) | 2023 | name in abstract: voretigene neparvovec |
| PMID 35342187 | Response to "Comment on the Article: Subretinal Bleb of Voretigene Neparvovec". | Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) | 2023 | name in title: voretigene neparvovec |
| PMID 35342188 | Comment on the Article: Subretinal Bleb of Voretigene Neparvovec. | Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) | 2023 | name in title: voretigene neparvovec |
| PMID 35609955 | Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec. | The British journal of ophthalmology | 2023 | name in title: voretigene neparvovec |
| PMID 35835501 | Subretinal deposits in young patients treated with voretigene neparvovec-rzyl for RPE65-mediated retinal dystrophy. | The British journal of ophthalmology | 2023 | name in title: voretigene neparvovec |
| PMID 35840489 | RNA-targeting strategies as a platform for ocular gene therapy. | Progress in retinal and eye research | 2023 | name in abstract: Luxturna |
| PMID 36096933 | Therapy with voretigene neparvovec. How to measure success? | Progress in retinal and eye research | 2023 | name in title: voretigene neparvovec |
| PMID 36103843 | Gene Therapy for Inherited Retinal Disease: Long-Term Durability of Effect. | Ophthalmic research | 2023 | name in abstract: voretigene neparvovec |
| PMID 36163489 | Retinal gene therapy in RPE-65 gene mediated inherited retinal dystrophy. | Eye (London, England) | 2023 | name in abstract: voretigene neparvovec |
| PMID 36167727 | Lessons Learned from the Development of the First FDA-Approved Gene Therapy Drug, Voretigene Neparvovec-rzyl. | Cold Spring Harbor perspectives in medicine | 2023 | name in title: voretigene neparvovec |
| PMID 36376080 | Overview of Retinal Gene Therapy: Current Status and Future Challenges. | Cold Spring Harbor perspectives in medicine | 2023 | name in abstract: Luxturna |
| PMID 36529826 | The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals. | Applied health economics and health policy | 2023 | name in abstract: voretigene neparvovec |